AAM Backs Bill To Boost Biosimilar Reimbursement

Proposed Legislation Would Temporarily Increase Rate To Average Sales Price Plus 8%

 
• By Dave Wallace

Draft US legislation that would seek to encourage biosimilar adoption by temporarily boosting reimbursement has received the backing of the AAM.

8% Dollars Stack
The bill would raise biosimilar reimbursement to the ASP +8% • Source: Alamy

More from Biosimilars

More from Products